Research Article: Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells
Introduction:
Liver cancer is one of the most common cancers and the fourth leading cause of cancer death worldwide in . Hepatocellular carcinomas account for approximately % of primary liver cancers. – Currently, conventional antitumor drugs lack selectivity for tumor tissue, – and the main barriers to chemotherapy are multidrug resistance (MDR) and drug toxicity.
Read more